Repurposing Established Cyclic Adenosine Monophosphate Reducing Agents for the Prevention and Therapy of Epidermal Growth Factor Receptor Inhibitor Resistance in Non-Small Cell Lung Cancer

Translational Lung Cancer Research - Hong Kong
doi 10.21037/tlcr.2018.03.04
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

AME Publishing Company


Related search